Fate Therapeutics (FATE) Other Non Operating Income (2012 - 2025)

Fate Therapeutics' Other Non Operating Income history runs 14 years deep, the most recent figure standing at $2.5 million for Q3 2025.

• Quarterly Other Non Operating Income fell 47.12% year-over-year to $2.5 million in Q3 2025, while the trailing twelve-month figure through Mar 2026 was $2.5 million (down 87.37% YoY) and the FY2025 annual result came in at $93000.0, down 98.43% from the prior year.
• Other Non Operating Income was $2.5 million for Q3 2025 at Fate Therapeutics, up from $50000.0 in the prior quarter.
• Across five years, Other Non Operating Income topped out at $26.1 million in Q4 2022 and bottomed at -$15.7 million in Q4 2023.
• A 5-year average of $4.9 million and a median of $4.9 million in 2021 frame the typical range for Other Non Operating Income.
• Peak annual rise in Other Non Operating Income reached 3972.67% in 2023, while the deepest fall reached 160.22% in 2023.
• Fate Therapeutics' Other Non Operating Income stood at $4.8 million in 2021, then jumped by 439.93% to $26.1 million in 2022, then slumped by 160.22% to -$15.7 million in 2023, then surged by 132.07% to $5.1 million in 2024, then slumped by 50.8% to $2.5 million in 2025.
• Business Quant data shows FATE's Other Non Operating Income at $2.5 million in Q3 2025, $50000.0 in Q2 2025, and $3.7 million in Q1 2025.